Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 31, 2017 - Issue 8
166
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

A new phenolic glycoside from Lindera nacusua

, , , , , , & show all
Pages 896-901 | Received 20 Jun 2016, Accepted 01 Oct 2016, Published online: 07 Nov 2016

References

  • Cheng W, Zhu CG, Xu WD, Fan XN, Yang YC, Li Y, Chen XG, Wang WJ, Shi JG. 2009. Chemical constituents of the bark of Machilus wangchiana and their biological activities. J Nat Prod. 72:2145–2152.10.1021/np900504a
  • Deng ZP, Zhong H, Cui SX, Wang FL, Xie YY, Yao QQ. 2011. Cytotoxic sesquiterpenoids from the fruits of Lindera communis. Fitoterapia. 82:1044–1046.10.1016/j.fitote.2011.06.012
  • Fu HZ, Li CJ, Yang JZ, Shen ZF, Zhang DM. 2011. Potential anti-inflammatory constituents of the stems of Gordonia chrysandra. J Nat Prod. 74:1066–1072.10.1021/np200021f
  • Huh G-W, Park J-H, Kang J-H, Jeong T-S, Kang HC, Baek N-I. 2014. Flavonoids from Lindera glauca Blume as low-density lipoprotein oxidation inhibitors. Nat Prod Res. 28:831–834.
  • Hiltunen E, Pakkanen TT, Alvila L. 2006. Phenolic compounds in silver birch (Betula pendula Roth) wood. Holzforschung. 60:519–527.
  • Koichi M, Yukiko Y, Sakiko M, Aiko S, Masao K. 2009. A new phenolic glycoside syringate from the bark of Juglans mandshurica MAXIM. var. sieboldiana MAKINO. J Nat Med. 63:220–222.
  • Li XW. 1982. Flora Republicae Popularis Sinicae (flora of China). Lauraceae. Beijing: Science Press.
  • Menendez JA, Vellon L, Rosen ST, Ruth Lupu. 2005. Novel molecular actions of the anti-obesity drug Orlistat (Xenical™) in cancer cells: Blockade of cell cycle progression, promotion of apoptotic cell death, PEA3-mediated transcriptional repression of Her-2/neu (erbB-2) oncogene, and sensitization to trastuzumab (Herceptin™)-induced cell growth inhibition. Cancer Res. 65:550–550.
  • Pandey PR, Liu W, Xing F, Fukuda K, Watabe K. 2012. Anti-cancer drugs targeting fatty acid synthase (FAS). Recent Pat Anticancer Drug Discov. 7:185–197.10.2174/157489212799972891
  • Sandra L, Ibáñez-Calero Valérie J, Sauvain Michel. 2009. A new anthraquinone isolated from Rumex Obtusifolius. Rev Bol Quim. 26:49–56.
  • Shimomura M, Ushikoshi H, Hattori A, Murata I, Ohno Y, Aoyama T, Kawasaki M, Nishigaki K, Takemura G, Fujiwara T. 2010. Treatment with Lindera strychnifolia reduces blood pressure by decreasing sympathetic nerve activity in spontaneously hypertensive rats. Am J Chin Med. 38:561–568.10.1142/S0192415X10008056
  • Suh WM, Park SB, Lee S, Kim HH, Suk K, Son JH, Kwon TK, Choi HG, Lee SH, Kim SH. 2011. Suppression of mast-cell-mediated allergic inflammation by Lindera obtusiloba. Exper Bio Med. 236:240–246.10.1258/ebm.2010.010274
  • Sun YR, Zhang SH, Shao RG, Hong-Wei HE. 2014. The synergistic effect of lidamycin and rituximab on human B cell lymphoma. Acta Pharmaceutica Sinica. 49:198–203.
  • Tanaka H, Nakamura T, Ichino K, Ito K, Tanaka T. 1990. Butanolides from Litsea japonica. Phytochemistry. 29:857–859.10.1016/0031-9422(90)80033-D
  • Wei GQ, Kong L, Zhang JS, Ma CY, Wu XQ, Li XR, Jiang HZ. 2016. Essential oil composition and antibacterial activity of Lindera nacusua (D. Don) Merr. Nat Prod Res. 3:1–3. doi:10.1080/14786419.2015.1135145.
  • Wei GQ, Zhang JS, Lei JP, Ma CY, Tong Y, Jiang HZ. 2016. Chemical constituents from Lindera nacusua (D. Don) Merr. Biochem Syst Ecol. 66:94–97.10.1016/j.bse.2016.03.004
  • Xiao M, Cao N, Fan JJ, Shen Y, Xu Q. 2011. Studies on flavonoids from the leaves of Lindera aggregate. J Chin Med Mater. 34:62–64.
  • Zhang W, Ye M, Zhan JX, Chen YJ, Guo D. 2004. Microbial glycosylation of four free anthraquinones by Absidia coerulea. Biotechnol Lett. 26:127–131.10.1023/B:BILE.0000012890.46665.02
  • Zhao QZ, Zhao YM, Wang KJ. 2006. Antinociceptive and free radical scavenging activities of alkaloids isolated from Lindera angustifolia Chen. J Ethnopharmacol. 106:408–413.10.1016/j.jep.2006.01.019

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.